Instil Bio, Inc.(TIL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TIL Instil Bio, Inc.

盘后交易 08-05 16:33:26 EDT

7.26

+0.01

+0.14%

盘后7.26

+0.000.00%

16:10 EDT

最高7.30	最低7.14	成交量9,583
今开7.18	昨收7.25	日振幅2.21%
总市值4,924万	流通市值2,583万	总股本678.20万
成交额6.91万	换手率0.27%	流通股本355.84万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TIL","market":"US","secType":"STK","nameCN":"Instil Bio, Inc.","latestPrice":7.26,"timestamp":1785960000000,"preClose":7.25,"halted":0,"volume":9583,"hourTrading":{"tag":"盘后","latestPrice":7.26,"preClose":7.26,"latestTime":"16:10 EDT","volume":12,"amount":87.12,"timestamp":1785960604626,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0013793103448275568,"floatShares":3558372,"shares":6781976,"eps":-7.038899,"marketStatus":"盘后交易","change":0.01,"latestTime":"08-05 16:33:26 EDT","open":7.175,"high":7.3,"low":7.1401,"amount":69118,"amplitude":0.022055,"askPrice":7.28,"askSize":2,"bidPrice":7.14,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-7.038899,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1785974400000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1616126400000,"exchange":"NASDAQ","adjPreClose":7.25,"postHourTrading":{"tag":"盘后","latestPrice":7.26,"preClose":7.26,"latestTime":"16:10 EDT","volume":12,"amount":87.12,"timestamp":1785960604626,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.030718,"impliedVol":5.6162,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/TIL","defaultTab":"news","newsList":[{"id":"2621005563","title":"来自嘉定的细胞科技，君赛生物为晚期癌症患者打开重生之门","url":"https://stock-news.laohu8.com/highlight/detail?id=2621005563","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2621005563?lang=zh_cn&edition=full","pubTime":"2026-03-24 14:05","pubTimestamp":1774332310,"startTime":"0","endTime":"0","summary":"上海嘉定的民营企业君赛生物应用肿瘤浸润淋巴细胞细胞科技，为晚期癌症患者打开重生之门。被“癌中之王”盯上后，他尝试了新型TIL疗法，重获新生胰腺癌被称为“癌中之王”，恶性程度极高，现有治疗手段疗效欠佳，预后极差，总体5年生存率不足10%。4年多前，M先生不幸罹患胰腺癌，尽管经历手术，但很快复发，尝试化疗、免疫、中药治疗后，一度陷入绝望。回忆起2022年的情形，M先生仍心有余悸。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202603/24/20260324637969.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202603/24/20260324637969.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260324/32093496.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["TIL","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518278421","title":"Instil Bio, Inc.盘中异动 早盘急速下跌6.20%报17.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518278421","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518278421?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:49","pubTimestamp":1741614583,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时49分，Instil Bio, Inc.股票出现波动，股价快速下挫6.20%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2730.30%、614.68%、94.89%，振幅较大的相关个股有Scisparc Ltd.、Impact Biomedical, Inc.、Trevi Therapeutics, Inc.，振幅分别为40.24%、28.59%、25.35%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214943a26a2bd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214943a26a2bd0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","TIL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518440860","title":"Instil Bio, Inc.2024财年实现净利润-74.14百万美元，同比增加52.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518440860","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518440860?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:01","pubTimestamp":1741449706,"startTime":"0","endTime":"0","summary":"3月9日，Instil Bio, Inc.公布财报，公告显示公司2024财年净利润为-74.14百万美元，同比增加52.47%；其中营业收入为0.00美元，每股基本收益为-11.39美元。从资产负债表来看，Instil Bio, Inc.总负债95.32百万美元，其中短期债务1.68百万美元，资产负债比为0.03，流动比率为0.16。机构评级：截至2025年3月9日，当前有3家机构对Instil Bio, Inc.目标价做出预测，其中目标均价为113.67美元，其中最低目标价为51.00美元，最高目标价为180.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000330a266b4d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000330a266b4d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516677748","title":"Instil Bio, Inc.盘中异动 股价大跌6.73%报17.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677748","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516677748?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:52","pubTimestamp":1741099933,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时52分，Instil Bio, Inc.股票出现异动，股价大幅下挫6.73%。截至发稿，该股报17.05美元/股，成交量2.3636万股，换手率0.36%，振幅7.99%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422521396394b2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422521396394b2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","TIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145020564","title":"Instil Bio公司2024年第四季度GAAP每股收益$(1.82)优于预期$(3.22)，公司拥有现金、现金等价物、受限现金和有价证券共$1.151亿，预计可支撑现有运营计划到2026年之后","url":"https://stock-news.laohu8.com/highlight/detail?id=1145020564","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1145020564?lang=zh_cn&edition=full","pubTime":"2025-03-04 20:20","pubTimestamp":1741090856,"startTime":"0","endTime":"0","summary":"Instil Bio报告季度每股亏损$，优于分析师一致预期的$，提高了43.48%。相比于去年同期的每股亏损$，增加了8.54%。以上内容来自Benzinga Earnings专栏，原文如下：Instil Bio  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 43.48 percent. This is a 8.54 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TIL","TSS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516632523","title":"Instil Bio, Inc.盘中异动 股价大涨8.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516632523","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516632523?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:31","pubTimestamp":1741012302,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时31分，Instil Bio, Inc.股票出现波动，股价大幅拉升8.21%。Instil Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。其相关个股中，Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Geovax Labs, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为47.20%、24.44%、22.45%，振幅较大的相关个股有Entero Therapeutics Inc.、Cibus, Inc.、Galmed Pharmaceuticals Ltd.，振幅分别为15.16%、9.55%、9.35%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223142abe63312&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223142abe63312&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TIL","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516304531","title":"Instil Bio, Inc.盘中异动 急速上涨5.02%报20.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516304531","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516304531?lang=zh_cn&edition=full","pubTime":"2025-03-01 04:58","pubTimestamp":1740776308,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日04时58分，Instil Bio, Inc.股票出现波动，股价快速拉升5.02%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.69%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010458289896c8a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010458289896c8a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","TIL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513216212","title":"Instil Bio, Inc.盘中异动 股价大跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513216212","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513216212?lang=zh_cn&edition=full","pubTime":"2025-02-22 02:13","pubTimestamp":1740161597,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日02时13分，Instil Bio, Inc.股票出现异动，股价急速下挫5.33%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Invivyd, Inc.、Osr Holdings, Inc.涨幅较大，Aditxt, Inc.、Nkgen Biotech, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为261.86%、243.77%、135.59%，振幅较大的相关个股有Osr Holdings, Inc.、Invivyd, Inc.、Osr Holdings Inc C/Wts 09/02/2028 ，振幅分别为76.52%、70.25%、57.50%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222021317962bad70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222021317962bad70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TIL","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512388114","title":"Instil Bio, Inc.盘中异动 下午盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512388114","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512388114?lang=zh_cn&edition=full","pubTime":"2025-02-20 02:03","pubTimestamp":1739988201,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日02时03分，Instil Bio, Inc.股票出现波动，股价大幅下挫5.00%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220020321a24c216f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220020321a24c216f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TIL","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512652601","title":"Instil Bio, Inc.盘中异动 股价大涨7.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512652601","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512652601?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:39","pubTimestamp":1739889589,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时39分，Instil Bio, Inc.股票出现异动，股价快速上涨7.82%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Pulmatrix, Inc.涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为298.00%、103.52%、82.47%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Conduit Pharmaceuticals Inc.、Pulmatrix, Inc.，振幅分别为34.04%、26.83%、23.16%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021822394996279934&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021822394996279934&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TIL","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511998216","title":"Instil Bio, Inc.盘中异动 股价大跌9.82%报21.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511998216","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511998216?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:32","pubTimestamp":1739543561,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时32分，Instil Bio, Inc.股票出现波动，股价急速跳水9.82%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。其相关个股中，Moleculin Biotech, Inc.、Virpax Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Virpax Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为1022.88%、366.99%、332.98%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Theratechnologies Inc.、Virpax Pharmaceuticals, Inc.，振幅分别为20.20%、18.33%、17.24%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223241988589c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223241988589c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TIL","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511529419","title":"Instil Bio, Inc.盘中异动 股价大涨5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511529419","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511529419?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:01","pubTimestamp":1739458911,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时01分，Instil Bio, Inc.股票出现波动，股价快速上涨5.58%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，Edesa Biotech, Inc.、Enanta Pharmaceuticals, Inc.、Nutriband Inc C/Wts 涨幅较大，Edesa Biotech, Inc.、Tc Biopharm  Plc、Genprex, Inc.较为活跃，换手率分别为1611.04%、1104.80%、121.46%，振幅较大的相关个股有天演药业、Immatics N V C/Wts 01/07/2025 、Edesa Biotech, Inc.，振幅分别为103.88%、92.30%、73.65%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213230152a244b2ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213230152a244b2ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","TIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509747598","title":"Instil Bio, Inc.盘中异动 早盘股价大跌5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509747598","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509747598?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:52","pubTimestamp":1738939974,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日22时52分，Instil Bio, Inc.股票出现异动，股价大幅跳水5.40%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207225254a23d285d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207225254a23d285d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","TIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509270860","title":"Instil Bio, Inc.盘中异动 早盘股价大涨5.57%报23.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509270860","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509270860?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:51","pubTimestamp":1738853485,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时51分，Instil Bio, Inc.股票出现异动，股价急速上涨5.57%。截至发稿，该股报23.50美元/股，成交量5381股，换手率0.08%，振幅2.96%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206225125987c9285&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206225125987c9285&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","TIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508445491","title":"Instil Bio, Inc.盘中异动 早盘大幅跳水5.70%报20.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508445491","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508445491?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:48","pubTimestamp":1738594129,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时48分，Instil Bio, Inc.股票出现异动，股价急速下跌5.70%。Instil Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Invivyd, Inc.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为422.21%、359.55%、226.04%，振幅较大的相关个股有Hcw Biologics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Briacell Therapeutics Corp.，振幅分别为82.67%、50.76%、36.85%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224849abc10b78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224849abc10b78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TIL","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507969671","title":"Instil Bio, Inc.盘中异动 早盘股价大跌5.50%报22.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507969671","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507969671?lang=zh_cn&edition=full","pubTime":"2025-01-31 22:53","pubTimestamp":1738335196,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日22时53分，Instil Bio, Inc.股票出现波动，股价快速跳水5.50%。截至发稿，该股报22.69美元/股，成交量8554股，换手率0.13%，振幅2.54%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.49%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131225316a235466a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131225316a235466a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TIL","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507620126","title":"Instil Bio, Inc.盘中异动 早盘快速跳水5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507620126","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507620126?lang=zh_cn&edition=full","pubTime":"2025-01-31 00:02","pubTimestamp":1738252932,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日00时02分，Instil Bio, Inc.股票出现异动，股价快速下跌5.63%。Instil Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。其相关个股中，Tectonic Therapeutic, Inc.、Kazia Therapeutics Limited、Alterity Therapeutics Limited涨幅较大，Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃，换手率分别为1597.84%、211.53%、197.00%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Alterity Therapeutics Limited、Immatics N V C/Wts 01/07/2025 ，振幅分别为61.86%、61.86%、56.41%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013100021396144802&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013100021396144802&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TIL","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506176815","title":"Instil Bio, Inc.盘中异动 快速拉升7.86%报26.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506176815","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506176815?lang=zh_cn&edition=full","pubTime":"2025-01-28 23:16","pubTimestamp":1738077360,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日23时16分，Instil Bio, Inc.股票出现异动，股价快速拉升7.86%。Instil Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128231600a23278a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128231600a23278a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TIL","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505929862","title":"Instil Bio, Inc.盘中异动 早盘股价大跌5.45%报22.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505929862","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505929862?lang=zh_cn&edition=full","pubTime":"2025-01-24 23:40","pubTimestamp":1737733209,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日23时40分，Instil Bio, Inc.股票出现异动，股价急速下跌5.45%。Instil Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。其相关个股中，Evaxion Biotech As、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.涨幅较大，Evaxion Biotech As、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为3569.59%、1868.02%、1375.11%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Evaxion Biotech As、Windtree Therapeutics, Inc.，振幅分别为134.08%、112.09%、66.25%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012423400998721047&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012423400998721047&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TIL","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505012136","title":"Instil Bio, Inc.盘中异动 股价大涨5.73%报20.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505012136","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505012136?lang=zh_cn&edition=full","pubTime":"2025-01-23 23:04","pubTimestamp":1737644668,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日23时04分，Instil Bio, Inc.股票出现波动，股价急速上涨5.73%。截至发稿，该股报20.85美元/股，成交量2.2178万股，换手率0.34%，振幅7.61%。Instil Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123230428a22d105e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123230428a22d105e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TIL","BK4505"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"https://instilbio.com/","stockEarnings":[{"period":"1week","weight":-0.0055},{"period":"1month","weight":-0.0621},{"period":"3month","weight":-0.0949},{"period":"6month","weight":-0.0282},{"period":"1year","weight":-0.707},{"period":"ytd","weight":-0.3409}],"compareEarnings":[{"period":"1week","weight":0.0411},{"period":"1month","weight":0.0356},{"period":"3month","weight":0.0511},{"period":"6month","weight":0.1383},{"period":"1year","weight":0.2221},{"period":"ytd","weight":0.1311}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Instil Bio, Inc.总部位于德克萨斯州达拉斯，于2018年8月在特拉华州注册成立。该公司是一家临床阶段生物制药公司，致力于开发创新的自体肿瘤浸润淋巴细胞（TIL）治疗细胞疗法，以治疗癌症患者。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.065377},{"month":2,"riseRate":0.4,"avgChangeRate":0.010549},{"month":3,"riseRate":0.2,"avgChangeRate":-0.090446},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.137381},{"month":5,"riseRate":0.333333,"avgChangeRate":0.121818},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.089726},{"month":7,"riseRate":0.5,"avgChangeRate":0.042071},{"month":8,"riseRate":0.666667,"avgChangeRate":0.048208},{"month":9,"riseRate":0.2,"avgChangeRate":0.663025},{"month":10,"riseRate":0.2,"avgChangeRate":-0.170435},{"month":11,"riseRate":0.2,"avgChangeRate":-0.206869},{"month":12,"riseRate":0.2,"avgChangeRate":-0.210371}],"exchange":"NASDAQ","name":"Instil Bio, Inc.","nameEN":"Instil Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Instil Bio, Inc.(TIL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Instil Bio, Inc.(TIL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Instil Bio, Inc.,TIL,Instil Bio, Inc.股票,Instil Bio, Inc.股票老虎,Instil Bio, Inc.股票老虎国际,Instil Bio, Inc.行情,Instil Bio, Inc.股票行情,Instil Bio, Inc.股价,Instil Bio, Inc.股市,Instil Bio, Inc.股票价格,Instil Bio, Inc.股票交易,Instil Bio, Inc.股票购买,Instil Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Instil Bio, Inc.(TIL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Instil Bio, Inc.(TIL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}